BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2892037)

  • 1. Are children with lymphoblastic leukaemia resistant to 6-mercaptopurine because of 5'-nucleotidase?
    Pieters R; Huismans DR; Veerman AJ
    Lancet; 1987 Dec; 2(8573):1471. PubMed ID: 2892037
    [No Abstract]   [Full Text] [Related]  

  • 2. [Enzymatic activity of lymphoid cells in malignant lymphoid proliferations in children].
    Demeocq F
    Ann Pediatr (Paris); 1984 Oct; 31(9):755-62. PubMed ID: 6098215
    [No Abstract]   [Full Text] [Related]  

  • 3. Relationship of 5'-nucleotidase activity and antileukemic effect in 2'-deoxycoformycin therapy.
    Wortmann RL; Holcenberg J; Poplack DG
    Cancer Treat Rep; 1982 Feb; 66(2):387-90. PubMed ID: 6275991
    [No Abstract]   [Full Text] [Related]  

  • 4. Resistance to 6-mercaptopurine. III. Deletion of a 5'-nucleotidase in a 6-mercaptopurine-resistant subline of the Ehrlich ascites carcinoma.
    PATERSON AR; HORI A
    Can J Biochem Physiol; 1963 Jun; 41():1339-48. PubMed ID: 13941819
    [No Abstract]   [Full Text] [Related]  

  • 5. Is maintenance therapy necessary for acute lymphoblastic leukaemia?
    Seshadri R; Turner DR
    Lancet; 1986 Aug; 2(8504):452-3. PubMed ID: 2874427
    [No Abstract]   [Full Text] [Related]  

  • 6. Lymphocyte ecto-5'-nucleotidase activity as a marker of B-cell maturation.
    Boss GR; Thompson LF; Spiegelberg HL; Waldmann TA; O'Connor RD; Hamburger RN; Seegmiller JE
    Trans Assoc Am Physicians; 1979; 92():309-15. PubMed ID: 232944
    [No Abstract]   [Full Text] [Related]  

  • 7. [Enzymes of purine nucleotide catabolism in lymphocytes in normal states and in chronic lymphoid leukemia].
    Filanovskaia LI; Vartanian NL; Togo AV; Samuskevich IG; Blinov MN
    Vopr Med Khim; 1985; 31(3):48-53. PubMed ID: 2992163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of 5'nucleotidase in acute lymphoblastic leukemia with the common-ALL phenotype.
    Veerman AJ; Hogeman PH; van Zantwijk CH; Bezemer PD
    Leuk Res; 1985; 9(10):1227-9. PubMed ID: 2999518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purine pathway enzyme abnormalities in acute lymphoblastic leukemia.
    Poplack DG; Blatt J; Reaman G
    Cancer Res; 1981 Nov; 41(11 Pt 2):4821-23. PubMed ID: 6271395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are children with lymphoblastic leukaemia given enough 6-mercaptopurine?
    Lennard L; Lilleyman JS
    Lancet; 1987 Oct; 2(8562):785-7. PubMed ID: 2888996
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of 5'nucleotidase in therapy-resistance of childhood leukemia.
    Pieters R; Veerman AJ
    Med Hypotheses; 1988 Sep; 27(1):77-80. PubMed ID: 2849709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 6-Mercaptopurine: apparent lack of relation between prescribed dose and biological effect in children with leukaemia.
    Herber S; Lennard L; Lilleyman JS; Maddocks J
    Br J Cancer; 1982 Jul; 46(1):138-41. PubMed ID: 6954968
    [No Abstract]   [Full Text] [Related]  

  • 13. The heterogeneity of 5'-nucleotidase activity in lymphoblasts of acute lymphoblastic leukemia, demonstrated by an improved cytochemical method.
    Pangalis GA; Tsavaris NB; Roussou PA
    Biomed Pharmacother; 1984; 38(9-10):444-8. PubMed ID: 6099151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance revealed in acute lymphoblastic leukemia.
    Aster JC; DeAngelo DJ
    Nat Med; 2013 Mar; 19(3):264-5. PubMed ID: 23467232
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of folate supplements on 6-mercaptopurine remission maintenance therapy in childhood leukaemia.
    Lennard L; Lilleyman JS; Maddocks JL
    Br J Cancer; 1986 Jan; 53(1):115-9. PubMed ID: 3456241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of 5'-nucleotidase as biochemical marker in leukemias and lymphomas.
    Gutensohn W; Thiel E; Emmerich B
    Klin Wochenschr; 1983 Jan; 61(1):57-62. PubMed ID: 6300512
    [No Abstract]   [Full Text] [Related]  

  • 17. Disturbance of 6-mercaptopurine metabolism by cotrimoxazole in childhood lymphoblastic leukaemia.
    Rees CA; Lennard L; Lilleyman JS; Maddocks JL
    Cancer Chemother Pharmacol; 1984; 12(2):87-9. PubMed ID: 6607783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetics and mechanisms of NT5C2-driven chemotherapy resistance in relapsed ALL.
    Dieck CL; Ferrando A
    Blood; 2019 May; 133(21):2263-2268. PubMed ID: 30910786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclic chemotherapy in acute lymphoblastic leukaemia of childhood: 5-year survivals.
    Vowels MR; Willoughby ML
    Arch Dis Child; 1973 Jun; 48(6):436-40. PubMed ID: 4514541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism for ara-CTP catabolism in human leukemic cells and effect of deaminase inhibitors on this process.
    Fridland A; Verhoef V
    Semin Oncol; 1987 Jun; 14(2 Suppl 1):262-8. PubMed ID: 3035721
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.